Paul Tough

And so the idea that parents need a strategy to persuade their kids to take medication felt really out of keeping with the research that I was reading, that medication works for some kids. but it doesn't work for all kids, that on the whole, the benefits of stimulant medication outweigh the deficits for most people. But for individual kids, sometimes it is not the right choice.

And I don't think that it's the job of parents to try to persuade their kids to keep taking this medication when they don't want to, as the research shows that lots of them don't want to and lots of them stop. And so these articles that from...

And I don't think that it's the job of parents to try to persuade their kids to keep taking this medication when they don't want to, as the research shows that lots of them don't want to and lots of them stop. And so these articles that from...

And I don't think that it's the job of parents to try to persuade their kids to keep taking this medication when they don't want to, as the research shows that lots of them don't want to and lots of them stop. And so these articles that from...

Attitude magazine that I mentioned that they're responding to, were all in one way or another trying to give parents arguments and approaches to try to convince their kids to take this medication. And so that's what I wrote about. It's true I didn't go follow up and interview these people because I was just quoting accurately the articles that they wrote in this magazine.

Attitude magazine that I mentioned that they're responding to, were all in one way or another trying to give parents arguments and approaches to try to convince their kids to take this medication. And so that's what I wrote about. It's true I didn't go follow up and interview these people because I was just quoting accurately the articles that they wrote in this magazine.

Attitude magazine that I mentioned that they're responding to, were all in one way or another trying to give parents arguments and approaches to try to convince their kids to take this medication. And so that's what I wrote about. It's true I didn't go follow up and interview these people because I was just quoting accurately the articles that they wrote in this magazine.

And I think that the magazine felt wounded by the fact that I'd identified these articles as being a part of that movement.

And I think that the magazine felt wounded by the fact that I'd identified these articles as being a part of that movement.

And I think that the magazine felt wounded by the fact that I'd identified these articles as being a part of that movement.

I think so, yeah. I mean, I think there's a mix of feelings about it. I think there are hopes that that sort of, you know, intense scientific research will help us. But I think there are more people, including some of the researchers who I wrote about, who said that that's not where our research focus is going to be most useful. That there may be two directions that seem most useful.

I think so, yeah. I mean, I think there's a mix of feelings about it. I think there are hopes that that sort of, you know, intense scientific research will help us. But I think there are more people, including some of the researchers who I wrote about, who said that that's not where our research focus is going to be most useful. That there may be two directions that seem most useful.

I think so, yeah. I mean, I think there's a mix of feelings about it. I think there are hopes that that sort of, you know, intense scientific research will help us. But I think there are more people, including some of the researchers who I wrote about, who said that that's not where our research focus is going to be most useful. That there may be two directions that seem most useful.

One is what Joel Nigg is doing and trying to figure out if there are subtypes within this group that is diagnosed with ADHD who have different problems with different maybe genetic signatures and different needs for treatment.

One is what Joel Nigg is doing and trying to figure out if there are subtypes within this group that is diagnosed with ADHD who have different problems with different maybe genetic signatures and different needs for treatment.

One is what Joel Nigg is doing and trying to figure out if there are subtypes within this group that is diagnosed with ADHD who have different problems with different maybe genetic signatures and different needs for treatment.

And if we, instead of saying you've got ADHD or you don't, if we can be more precise in what intensity of ADHD, what type of ADHD you have, we can give you more helpful treatment suggestions. And then I think the other angle that I find really reassuring is to think about environments. So instead of to think of this as just a Think about the environmental side of it.

And if we, instead of saying you've got ADHD or you don't, if we can be more precise in what intensity of ADHD, what type of ADHD you have, we can give you more helpful treatment suggestions. And then I think the other angle that I find really reassuring is to think about environments. So instead of to think of this as just a Think about the environmental side of it.

And if we, instead of saying you've got ADHD or you don't, if we can be more precise in what intensity of ADHD, what type of ADHD you have, we can give you more helpful treatment suggestions. And then I think the other angle that I find really reassuring is to think about environments. So instead of to think of this as just a Think about the environmental side of it.

And a lot of the research suggests that as environments change for young people, their symptoms change as well. But mostly what we see is that just kind of happens as you go through life. There is not a big push. And I think there hasn't been a lot of study of if we are actually intentional about how we change young people's environments, can we predictably make a difference in their symptoms?